Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Indoor Drinking Fountains: Famous Home Advancements during the Pandemic - 2Addressing sleep apnea early might decrease chances of developing Parkinson's disease
- 3Insurance warning signs in doctors’ offices might discourage patients from speaking openly about their health
- 4Most normal matter in the universe isn't found in planets, stars or galaxies – an astronomer explains where it's distributed
- 5The Way to Business: Startup Illustrations Learned
- The best overlooked performances of 2025
- Europe pledges over €15bn for clean energy for Africa
- Find the Mysteries of Powerful Using time productively: Augmenting Efficiency and Proficiency
- Vote in favor of Your #1 4\u00d74 SUVs
- Many European nations want Israel to cancel 19 new settlement plans
- The most effective method to Quick Track Your Outcome in Advanced Showcasing with a Web-based Degree
- Exploring Being a parent: A Survey of \Bits of knowledge and Guidance for Guardians\ Nurturing Book
- SpaceX launches Starlink missions in dual-coast spaceflight doubleheader (videos)
- How to Select Ergonomic Chairs for Lumbar Spine Protection
